Skip Navigation



Europace Advance Access published online on May 24, 2008
Europace, doi:10.1093/europace/eun132
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/8/1012    most recent
eun132v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Takahashi, K.
Right arrow Articles by Nakanishi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, K.
Right arrow Articles by Nakanishi, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

CASE REPORT

Successful radiofrequency catheter ablation of atrial fibrillation late after modified Fontan operation

Kazuhiro Takahashi1,*, Morio Shoda2, Tetsuyuki Manaka2 and Toshio Nakanishi1

1 Department of Pediatric Cardiology, Tokyo Women’s Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan; 2 Department of Cardiology, Tokyo Women’s Medical University, Tokyo, Japan

The mechanisms responsible for atrial fibrillation (AF) in post-operative Fontan patients are unclear, and the role of catheter ablation for treating AF is not well defined. We present a case of an 18-year-old woman who experienced drug-resistant paroxysmal AF late after the Fontan operation. We eliminated the AF by the radiofrequency catheter ablation of atrial substrates with complex fractionated atrial electrograms (CFAEs). The patient remains on anti-arrhythmic therapy and has not experienced any recurrence since the catheter ablation. Right atrial substrate modification via a CFAE-targeted catheter ablation might be an adjunct therapeutic option for selected post-Fontan patients with AF.

* Corresponding author. Tel: +81 3 3353 8111; fax: +81 3 3356 0446. E-mail address: bigkaz{at}mua.biglobe.ne.jp

Manuscript submitted 19 February 2008. Accepted after revision 26 April 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al.
Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'
Europace, July 1, 2009; 11(7): 860 - 885.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.